Relationship between improvement of glycaemic control and reduction of major cardiovascular events in 15 cardiovascular outcome trials: A meta‐analysis with meta‐regression-Reference-Cited by-同舟云学术

Relationship between improvement of glycaemic control and reduction of major cardiovascular events in 15 cardiovascular outcome trials: A meta‐analysis with meta‐regression

Published:2020-05-07 Issue:8 Volume:22 Page:1397-1405
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Giugliano Dario¹^ORCID,Bellastella Giuseppe¹,Longo Miriam¹,Scappaticcio Lorenzo¹,Maiorino Maria Ida²^ORCID,Chiodini Paolo³,Esposito Katherine²

Affiliation:

1. Division of Endocrinology and Metabolic Diseases, Department of Advanced Medical and Surgical SciencesUniversità della Campania Luigi Vanvitelli Naples Italy

2. Diabetes Unit, Department of Advanced Medical and Surgical SciencesUniversità della Campania Luigi Vanvitelli Naples Italy

3. Medical Statistics UnitUniversità della Campania Luigi Vanvitelli Naples Italy

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14047

Reference36 articles.

1. Food and Drug Administration. Guidance for industry: diabetes mellitus ‐ evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes. Silver Spring Maryland: Food and Drug Administration December 2008.www.fda.gov/downloads/Drugs/Guidances/ucm071627.pdf. Accessed March 24 2020.

2. Heart failure and type 2 diabetes: From cardiovascular outcome trials, with hope

3. Safety of SGLT2 Inhibitors in Patients with Diabetes Mellitus

4. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary

5. 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2020

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular Protective Properties of GLP-1 Receptor Agonists: More than Just Diabetic and Weight Loss Drugs;Journal of Clinical Medicine;2024-08-09

2. Management of Type 2 Diabetes Mellitus: Synopsis of the Department of Veterans Affairs and Department of Defense Clinical Practice Guideline;Mayo Clinic Proceedings;2024-08

3. Heart failure phenotypes and clinical and laboratory features of patients with type 2 diabetes in inpatient endocrinology and cardiology practice;Meditsinskiy sovet = Medical Council;2024-05-19

4. Circular RNAs: a small piece in the heart failure puzzle;Functional & Integrative Genomics;2024-05-17

5. Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines;Cardiovascular Therapy and Prevention;2024-04-01